<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05109143</url>
  </required_header>
  <id_info>
    <org_study_id>IEC/2020/81/MA13</org_study_id>
    <nct_id>NCT05109143</nct_id>
  </id_info>
  <brief_title>Efficacy of Rectal Indomethacin in Prevention of Post-operative Pancreatitis After Pancreaticoduodenectomy</brief_title>
  <official_title>Efficacy of Rectal Indomethacin in Prevention of Post-operative Pancreatitis After Pancreaticoduodenectomy - a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Liver and Biliary Sciences, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Liver and Biliary Sciences, India</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pancreatico-duodenectomy is one of the commonly performed procedure for periampullary/distal&#xD;
      cholangio/head of pancreas carcinoma. Post operative pancreatitis is an emerging concept,&#xD;
      recently being studied as one of the most important contributing factor of Post-operative&#xD;
      pancreatic fistula, which is one of the major complication of pancreatoduodenectomy. Rectal&#xD;
      indomethacin, a type of non-steroidal anti-inflammatory drug, when given in a single dose has&#xD;
      been shown to prevent pancreatitis in patients undergoing ERCP. In this study, we will be&#xD;
      administering rectal indomethacin at the time of induction of anesthesia to the experimental&#xD;
      arm of the study and compare the results in terms of incidence of post-operative pancreatitis&#xD;
      in the two groups.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 17, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative Pancreatitis</measure>
    <time_frame>first 30 days following pancreatoduodenectomy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative Pancreatic Fistula</measure>
    <time_frame>first 30 days following pancreatoduodenectomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>delayed gastric emptying</measure>
    <time_frame>First 30 days following pancreatoduodenectomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intra-abdominal abscess</measure>
    <time_frame>first 30 days following pancreatoduodenectomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>First 30 days following pancreatoduodenectomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>First 30 days following pancretoduodenectomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>risk factors of post-operative pancreatitis</measure>
    <time_frame>first 30 days following pancreatoduodenectomy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Pancreatoduodenectomy</condition>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard Medical Treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will be administered 100mg of Indomethacin Suppository sigle dose at the time of induction of anesthesia with Standard Medical Treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Indomethacin suppository</intervention_name>
    <description>100mg Indomethacin Suppository administered at the time of Induction</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Medical Treatment</intervention_name>
    <description>Standard Medical Treatment</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All consenting adults planned to undergo pancreatoduodenectomy,&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  asthma&#xD;
&#xD;
          -  allergic reactions to NSAIDs&#xD;
&#xD;
          -  CKD&#xD;
&#xD;
          -  internal hemorrhoids&#xD;
&#xD;
          -  anti-platelet medications&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Viniyendra Pamecha, FEBS</last_name>
    <role>Study Director</role>
    <affiliation>Institute of Liver &amp; Biliary Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anubhav Harshit Kumar, MCh</last_name>
    <phone>8860188337</phone>
    <email>anubhav.pawar@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anish Gupta, MCh</last_name>
    <phone>9796020957</phone>
    <email>dranishgupta@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute of Liver &amp; Biliary Sciences</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110070</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Anubhav, MS</last_name>
      <phone>01146300000</phone>
      <email>anubhav.pawar@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 26, 2021</study_first_submitted>
  <study_first_submitted_qc>November 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2021</study_first_posted>
  <last_update_submitted>November 4, 2021</last_update_submitted>
  <last_update_submitted_qc>November 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Indomethacin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

